Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

7-hydroxy Methotrexate (7-hydroxy MTX) is a phase I metabolite of MTX (Item No. 13960), which is converted by hepatic aldehyde oxidases.1 Elimination of 7-hydroxy MTX is associated with the multi-drug transporters Abcc2, Abcc3, and Abcg2 in transgenic mouse models. It and the parent compound rapidly accumulate when all three transporters are absent.2 Formulations containing methotrexate have been used in the treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions.3,4 Various methods have been described to quantify 7-hydroxy MTX levels during cancer therapy to avoid toxicity.5,6
WARNING This product is not for human or veterinary use.
1. The relative toxicites of methotrexate and aminopterin. Biochem. Pharmacol. 15(5), 555-561 (1966).
2. Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-
3. Anti-
4. Medical termination of pregnancy. N. Engl. J. Med. 342(13), 946-956 (2000).
5. Development of an assay for methotrexate and its metabolites 7-
6. The influence of 7-